Nasdaq: regn investor alert: berger montague advises regeneron pharmaceuticals (nasdaq: regn) investors of a march 10, 2025 deadline

Philadelphia, jan. 17, 2025 (globe newswire) -- berger montague pc advises investors that a securities class action lawsuit has been filed against regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) on behalf of purchasers of regeneron securities between november 2, 2023 through october 30, 2024, inclusive (the “class period”).
REGN Ratings Summary
REGN Quant Ranking